• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素可增强顺铂对卵巢癌细胞的化疗效果,且与褪黑素1型受体无关。

Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors.

作者信息

Zemła Agata, Grzegorek Irmina, Dzięgiel Piotr, Jabłońska Karolina

机构信息

Department of Histology and Embriology, Wroclaw Medical University, Wroclaw, Poland.

Department of Histology and Embriology, Wroclaw Medical University, Wroclaw, Poland

出版信息

In Vivo. 2017 Sep-Oct;31(5):801-809. doi: 10.21873/invivo.11133.

DOI:10.21873/invivo.11133
PMID:28882945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5656852/
Abstract

BACKGROUND/AIM: Melatonin (MLT), through the interaction with membrane melatonin receptors MT1, can improve the effectiveness of cytostatic agents, including cisplatin (CP). The aim of this study was to examine the synergistic effect of MLT and CP in three cell lines: IOSE 364, SK-OV-3 and OVCAR-3, as well as to assess the role of MT1 receptors in this mechanism.

MATERIALS AND METHODS

Using the SRB assay we investigated the effect of different concentrations of CP and MLT on cell viability. Tests, using luzindole - MT1 inhibitor, allowed us to assess the potential involvement of MT1 in the mechanism of MLT action.

RESULTS

MLT at certain concentrations demonstrated a synergistic effect in combination with CP. The addition of luzindole did not affect the action of MLT in combination with CP.

CONCLUSION

In summary, the synergistic effect of MLT with CP seems to be independent of membrane MT1 receptors.

摘要

背景/目的:褪黑素(MLT)通过与膜褪黑素受体MT1相互作用,可提高包括顺铂(CP)在内的细胞抑制剂的有效性。本研究旨在检测MLT与CP在三种细胞系(IOSE 364、SK-OV-3和OVCAR-3)中的协同作用,并评估MT1受体在该机制中的作用。

材料与方法

使用SRB检测法,我们研究了不同浓度的CP和MLT对细胞活力的影响。使用MT1抑制剂鲁辛朵进行的试验,使我们能够评估MT1在MLT作用机制中的潜在参与情况。

结果

特定浓度的MLT与CP联合显示出协同作用。添加鲁辛朵并不影响MLT与CP联合的作用。

结论

总之,MLT与CP的协同作用似乎独立于膜MT1受体。

相似文献

1
Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors.褪黑素可增强顺铂对卵巢癌细胞的化疗效果,且与褪黑素1型受体无关。
In Vivo. 2017 Sep-Oct;31(5):801-809. doi: 10.21873/invivo.11133.
2
Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.抗雌激素调节乳腺癌和卵巢癌细胞系中MT1褪黑素受体的表达。
Oncol Rep. 2006 Jan;15(1):231-5.
3
Melatonin MT and MT Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle.褪黑素 MT 和 MT 受体在光/暗周期体温调节中表现出不同的作用。
Int J Mol Sci. 2019 May 17;20(10):2452. doi: 10.3390/ijms20102452.
4
Expression of the MT1 melatonin receptor in ovarian cancer cells.MT1褪黑素受体在卵巢癌细胞中的表达。
Int J Mol Sci. 2014 Dec 12;15(12):23074-89. doi: 10.3390/ijms151223074.
5
Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity.褪黑素通过MT1受体和抗氧化活性保护小鼠免受顺铂诱导的卵巢损伤。
Biol Reprod. 2017 Jun 1;96(6):1244-1255. doi: 10.1093/biolre/iox053.
6
Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.鲁辛朵尔而非4-苯基-2-丙酰胺基四氢萘(4P-PDOT)可减弱褪黑素对小鼠结肠38癌体外生长的抑制作用。
Neuro Endocrinol Lett. 2009;30(5):657-62.
7
Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells.褪黑素通过使 ERK/p90 核糖体 S6 激酶/热休克蛋白 27 去磷酸化协同增强顺铂诱导的 SK-OV-3 细胞凋亡。
J Pineal Res. 2012 Mar;52(2):244-52. doi: 10.1111/j.1600-079X.2011.00935.x. Epub 2011 Nov 3.
8
The Regulatory Mechanism of MLT/MT1 Signaling on the Growth of Antler Mesenchymal Cells.MLT/MT1 信号对鹿茸间充质细胞生长的调控机制。
Molecules. 2017 Oct 23;22(10):1793. doi: 10.3390/molecules22101793.
9
Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.褪黑素对肝癌 HepG2 细胞系细胞内信号通路的调节作用:MT1 受体的作用。
J Pineal Res. 2011 Nov;51(4):463-71. doi: 10.1111/j.1600-079X.2011.00910.x. Epub 2011 Jul 1.
10
The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.褪黑素受体拮抗剂鲁辛朵尔和4-苯基-2-丙酰胺基四氢萘(4-P-PDOT)对大鼠下丘脑-垂体系统中褪黑素依赖性抗利尿激素和促肾上腺皮质激素(ACTH)释放的影响。体外和体内研究。
J Physiol Pharmacol. 2014 Dec;65(6):777-84.

引用本文的文献

1
Melatonin Inhibits Endometriosis Growth via Specific Binding and Inhibition of EGFR Phosphorylation.褪黑素通过特异性结合和抑制表皮生长因子受体(EGFR)磷酸化来抑制子宫内膜异位症的生长。
J Pineal Res. 2024 Nov;76(8):e70022. doi: 10.1111/jpi.70022.
2
Significance of Melatonin in the Regulation of Circadian Rhythms and Disease Management.褪黑素在调节昼夜节律和疾病管理中的意义。
Mol Neurobiol. 2024 Aug;61(8):5541-5571. doi: 10.1007/s12035-024-03915-0. Epub 2024 Jan 11.
3
Regulation of Adipose-Derived Stem Cell Activity by Melatonin Receptors in Terms of Viability and Osteogenic Differentiation.褪黑素受体对脂肪来源干细胞活性在活力和成骨分化方面的调控
Pharmaceuticals (Basel). 2023 Sep 1;16(9):1236. doi: 10.3390/ph16091236.
4
Cytotoxic Activity of Melatonin Alone and in Combination with Doxorubicin and/or Dexamethasone on Diffuse Large B-Cell Lymphoma Cells in In Vitro Conditions.褪黑素单独及与阿霉素和/或地塞米松联合在体外条件下对弥漫性大B细胞淋巴瘤细胞的细胞毒性作用
J Pers Med. 2023 Aug 27;13(9):1314. doi: 10.3390/jpm13091314.
5
Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation.褪黑素可逆转卵巢癌细胞的瓦博格样代谢并降低线粒体膜电位,且不依赖于 MT1 受体的激活。
Molecules. 2022 Jul 7;27(14):4350. doi: 10.3390/molecules27144350.
6
Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.褪黑素在癌症治疗中的应用:现有知识与未来机遇。
Molecules. 2021 Apr 25;26(9):2506. doi: 10.3390/molecules26092506.
7
Melatonin and its mechanism of action in the female reproductive system and related malignancies.褪黑素及其在女性生殖系统和相关恶性肿瘤中的作用机制。
Mol Cell Biochem. 2021 Aug;476(8):3177-3190. doi: 10.1007/s11010-021-04151-z. Epub 2021 Apr 17.
8
Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC).褪黑素受体MT1和MT2在非小细胞肺癌(NSCLC)中的预后影响
Cancers (Basel). 2019 Jul 17;11(7):1001. doi: 10.3390/cancers11071001.
9
Mitochondrial functions and melatonin: a tour of the reproductive cancers.线粒体功能与褪黑素:生殖系统癌症之旅。
Cell Mol Life Sci. 2019 Mar;76(5):837-863. doi: 10.1007/s00018-018-2963-0. Epub 2018 Nov 14.
10
Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers.褪黑素:激素依赖性癌症中的一种抗肿瘤剂。
Int J Endocrinol. 2018 Oct 2;2018:3271948. doi: 10.1155/2018/3271948. eCollection 2018.

本文引用的文献

1
Melatonin as an antioxidant: under promises but over delivers.褪黑素作为一种抗氧化剂:承诺过多,兑现不足。
J Pineal Res. 2016 Oct;61(3):253-78. doi: 10.1111/jpi.12360. Epub 2016 Sep 1.
2
Update on melatonin receptors: IUPHAR Review 20.褪黑素受体最新进展:药理学与治疗学国际联合会综述20
Br J Pharmacol. 2016 Sep;173(18):2702-25. doi: 10.1111/bph.13536. Epub 2016 Aug 8.
3
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.MT1和MT2褪黑素受体:治疗前景
Annu Rev Pharmacol Toxicol. 2016;56:361-83. doi: 10.1146/annurev-pharmtox-010814-124742. Epub 2015 Oct 23.
4
Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism.褪黑素作为一种强效且可诱导的内源性抗氧化剂:合成与代谢。
Molecules. 2015 Oct 16;20(10):18886-906. doi: 10.3390/molecules201018886.
5
Melatonin, the Hormone of Darkness: From Sleep Promotion to Ebola Treatment.褪黑素,黑暗中的激素:从促进睡眠到治疗埃博拉
Brain Disord Ther. 2014;4(1). doi: 10.4172/2168-975X.1000151.
6
Expression of the MT1 melatonin receptor in ovarian cancer cells.MT1褪黑素受体在卵巢癌细胞中的表达。
Int J Mol Sci. 2014 Dec 12;15(12):23074-89. doi: 10.3390/ijms151223074.
7
Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trial.接受化疗的癌症患者中褪黑素:一项随机、双盲、安慰剂对照试验。
Anticancer Res. 2014 Dec;34(12):7327-37.
8
RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D.RORα 和 ROR γ 在人体皮肤中表达,作为内源性产生的非钙调素 20-羟基和 20,23-二羟维生素 D 的受体。
FASEB J. 2014 Jul;28(7):2775-89. doi: 10.1096/fj.13-242040. Epub 2014 Mar 25.
9
YKL-40 expression could be a poor prognostic marker in the breast cancer tissue.YKL-40表达可能是乳腺癌组织中一个预后不良的标志物。
Tumour Biol. 2014 Jan;35(1):277-86. doi: 10.1007/s13277-013-1036-0. Epub 2013 Aug 6.
10
Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells.褪黑素对癌细胞促凋亡作用的相关机制。
Int J Mol Sci. 2013 Mar 25;14(4):6597-613. doi: 10.3390/ijms14046597.